SwedenTuberculosis profile
Population  2014 9.7 million
Estimates of TB burden * 2014 Number (thousands) Rate
(per 100 000 population)
Mortality (excludes HIV+TB) 0.025 (0.025–0.026) 0.26 (0.26–0.27)
Mortality (HIV+TB only) <0.01 (<0.01–<0.01) 0.02 (0.01–0.03)
Prevalence  (includes HIV+TB) 0.91 (0.39–1.7) 9.4 (4–17)
Incidence  (includes HIV+TB) 0.72 (0.63–0.82) 7.5 (6.5–8.4)
Incidence (HIV+TB only) 0.024 (0.018–0.03) 0.24 (0.19–0.3)
         
Case detection, all forms (%) 88 (77–100)    
Estimates of MDR-TB burden * 2014   New   Retreatment
% of TB cases with MDR-TB 3 (1.4–5.6) 11 (1.3–33)
MDR-TB cases among notified pulmonary
TB cases
11 (5–20) 4 (1–13)
TB case notifications 2014 New ** Relapse
Pulmonary, bacteriologically confirmed 313   4
Pulmonary, clinically diagnosed 44   0
Extrapulmonary 270   4
       
Total new and relapse 635    
Previously treated, excluding relapses 35    
Total cases notified 670    
Among 635 new and relapse cases:
53 (8%) cases aged under 15 years; male:female ratio: 1.1
Reported cases of RR-/MDR-TB 2014 New Retreatment Total **
Cases tested for RR-/MDR-TB 498 (159%) 23 (53%) 526
Laboratory-confirmed RR-/MDR-TB cases     18
Patients started on MDR-TB treatment ***     15
TB/HIV 2014 Number (%)
TB patients with known HIV status    
HIV-positive TB patients    
HIV-positive TB patients on co-trimoxazole preventive therapy (CPT)    
HIV-positive TB patients on antiretroviral therapy (ART)    
HIV-positive people screened for TB    
HIV-positive people provided with IPT    
Treatment success rate and cohort size (%) Cohort
New and relapse cases registered in 2013 (90) 597
Previously treated cases, excluding relapse, registered in 2013 (82) 34
HIV-positive TB cases, all types, registered in 2013    
RR-/MDR-TB cases started on second-line treatment in 2012 (83) 12
XDR-TB cases started on second-line treatment in 2012 (100) 2
Laboratories 2014  
Is second-line drug susceptibility testing available? Yes, in country
Financing TB control 2015  
National TB programme budget (US$ millions)  
* Ranges represent uncertainty intervals
** Includes cases with unknown previous TB treatment history
*** Includes patients diagnosed before 2014 and patients who were not laboratory-confirmed as having
RR-/MDR-TB
***
(Rate per 100 000 population per year)
Mortality graph
   Mortality  (excludes HIV+TB)

(Rate per 100 000 population)
Prevalence graph
   Prevalence

(Rate per 100 000 population per year)
Incidence graph
   Notified (new and relapse)   Incidence
   Incidence (HIV+TB only)

(Number of patients)
CPT ART graph
   HIV-positive TB patients
   on CPT   on ART

Treatment success rate (%)
tx success graph
   New   Retreatment
   New and relapse   Retreatment, excluding
relapse
   HIV-positive   RR-/MDR-TB   XDR-TB

 
 Data are as reported to WHO. Estimates of TB and MDR-TB burden are produced by WHO in consultation with countries.
 Generated: 2016-06-29 Data: www.who.int/tb/data